<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03069027</url>
  </required_header>
  <id_info>
    <org_study_id>3-2-17</org_study_id>
    <nct_id>NCT03069027</nct_id>
  </id_info>
  <brief_title>Efficacy of External Nasal Nerve Block in Prevention of Postoperative Agitation Following Nasal Surgeries</brief_title>
  <official_title>Efficacy of External Nasal Nerve Block on Postoperative Agitation Following Nasal Surgeries Under General Anesthesia. Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al Jedaani Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Al Jedaani Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergence agitation following general anaesthesia may lead to serious complications like
      self-extubation or removal of catheters, which can lead to hypoxia, aspiration pneumonia,
      bleeding or reoperation. Nose surgery is associated with a higher incidence of emergence
      agitation. The investigators planned to evaluate the efficacy of external nasal nerve block
      in prevention of postoperative agitation following external nasal surgeries under general
      anesthesia(GA).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2016</start_date>
  <completion_date type="Actual">July 1, 2017</completion_date>
  <primary_completion_date type="Actual">April 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative agitation</measure>
    <time_frame>Emergence is defined as the time interval from discontinuation of anesthesia to 5 min after extubation.</time_frame>
    <description>Assessment done using Richmond agitation- sedation scale (RASS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Quality of recovery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>dose of fentanyl</measure>
    <time_frame>intraoperative period in minutes</time_frame>
    <description>Fentanyl boluses were given in response to changes in hemodynamics (more than 15% increases in MAP and HR than the baseline values taken after induction by 5 minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morphine dose in PACU</measure>
    <time_frame>one hour in PACU</time_frame>
    <description>equivalent morphine dose in PACU (calculated using opioid:morphine equivalents of 100 Âµg i.v. fentanyl to 10 mg i.v. morphine; 75- 100 mg IV pethidine to 10 mg i.v. morphine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting in PACU</measure>
    <time_frame>one hour in PACU</time_frame>
    <description>Four-point nausea and vomiting scale (0=no nausea; 1=mild nausea; 2=severe nausea requiring antiemetics; and 3=retching, vomiting, or both) was also evaluated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation time</measure>
    <time_frame>Up to 15 after discontinuation of anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical time</measure>
    <time_frame>duration of surgery in minutes up to 3 hours</time_frame>
    <description>intraoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first verbal response time</measure>
    <time_frame>up to 15 minutes</time_frame>
    <description>period from discontinuation of anesthesia 'time zero' to 1st verbal response in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication of nasal block</measure>
    <time_frame>From injection to 24 hours postoperative</time_frame>
    <description>including local anesthetic systemic toxicity, vascular injury, intravascular injection of local anesthetic, and local hematoma.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Agitation States as Acute Reaction to Gross Stress</condition>
  <arm_group>
    <arm_group_label>Group I(control)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients allocated for external nasal nerve block with saline adrenaline 1/200,000 (placebo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II(block)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>'External nasal nerve block by Xylocaine, adrenaline'</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>External nasal nerve block</intervention_name>
    <description>Three single (midline injection) and 4 paired (bilateral injection) sites to block the external nasal sensation.</description>
    <arm_group_label>Group I(control)</arm_group_label>
    <arm_group_label>Group II(block)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline adrenaline</intervention_name>
    <arm_group_label>Group I(control)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xylocaine, adrenaline</intervention_name>
    <arm_group_label>Group II(block)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  110 adult patients of ASA physical status I and II,

          -  Age 20-60 years,

          -  Scheduled for elective external nasal surgeries in which nasal packing on each side
             was used postoperatively for 24 hours.

        Exclusion Criteria:

          1. History of uncontrolled hypertension,

          2. Ischemic or valvular heart disease,

          3. Use of MAO inhibitors or adrenergic blocking drugs,

          4. Cognitive impairment,

          5. Patients taking antipsychotics,

          6. Renal insufficiency or liver dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Al Jedaani group of hospitals</name>
      <address>
        <city>Jeddah</city>
        <state>Meccah</state>
        <zip>21462/7500</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2017</study_first_submitted>
  <study_first_submitted_qc>March 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <last_update_submitted>December 23, 2017</last_update_submitted>
  <last_update_submitted_qc>December 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al Jedaani Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Mohamed Ibrahim</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology- Zagazig University - Consultant of anesthesia</investigator_title>
  </responsible_party>
  <keyword>Nasal surgery</keyword>
  <keyword>external nasal nerve block</keyword>
  <keyword>postoperative agitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

